Iraj Sabahi Research Inc. Report issue

For profit Phase 4
Founded: Turlock CA United States (2014)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2017
NCT03082573
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

corticotropin (acthar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1